Skip to main content

Ventas Value Stock - Dividend - Research Selection

Ventas

ISIN: US92276F1003 , WKN: 878380

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of more than 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. References to ?Ventas? or the ?Company? mean Ventas, Inc. and its consolidated subsidiaries unless otherwise expressly noted. More information about Ventas and Lillibridge can be found at www.ventasreit.com and www.lillibridge.com.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Hurricane Milton puts $30B of Florida muni debt at risk - report

2024-10-09
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Ventas Announces Third Quarter 2024 Earnings Release Date and Conference Call

2024-10-07
CHICAGO - Ventas, Inc. will issue its third quarter 2024 earnings release after the close of trading on the New York Stock Exchange on Wednesday, October 30, 2024. A conference call to discuss those...

An October Surprise

2024-10-06
Real estate equities were the weakest of the 11 GICS equity sectors this week. Read more to see my thoughts.

Real estate stocks end in red amid geopolitical tensions

2024-10-05
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Wells Fargo upgrades 3, downgrades 2 healthcare REITs on price to earnings growth and yield

2024-10-01
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Welltower just downgraded at Wells Fargo, here's why

2024-10-01
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Ventas (VTR) was upgraded to a Buy Rating at Wells Fargo

2024-10-01
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Ventas just upgraded at Wells Fargo, here's why

2024-10-01
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Ventas Stock Rises 48.9% in Six Months: What You Should Know

2024-09-30
VTR is poised to gain from a favorable demand in senior housing, backed by an expected rise in senior citizens' population.

Looking Into Ventas's Recent Short Interest

2024-09-30
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.